PHARMACEUTICAL COMPOSITION AND A METHOD OF EFFECT ON RETICULOENDOTHELIUM SYSTEM, TREATMENT OF MUCOVISCIDOSIS AND CHRONIC PAIN SYNDROME ACCOMPANYING LOCOMOTOR SYSTEM AND ONCOLOGIC SICKNESSES Russian patent published in 1997 - IPC

FIELD: medicine. SUBSTANCE: composition has, g/100 ml aqueous solution: one or some pharmaceutically acceptable water-soluble compounds of boron 0.01-1; fluorine 0.01-1; magnesium 0.2-3; vanadium 0.001-0.6; manganese 0.02-2; iron 0.15-6; cobalt 0.002-1; nickel 0.01-2; copper 0.01-1; zinc 0.1-3 and molybdenum 0.001-8 that can not be precipitated each with other and showing neutral or acid pH value in an aqueous medium. Also, composition has glycine 0.1-2; glycerol 0.2-8; L-(+)-ascorbic acid 0.01-2; neutral or acid water-soluble and pharmaceutically acceptable ethylenediaminetetraacetic acid salt 0.01-3; potassium-sodium tartrate 0.01-10; succinic acid 0.001-2 and L-(+)-tartaric acid 0.01-2. The indicated pharmaceutical composition is used at every dose 5-500 drops, preferably, 50-150 drops. EFFECT: enhanced effectiveness of composition. 22 cl, 2 tbl